Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Programming other hormones that affect insulin.

C D Byrne1

  • 1Endocrinology and Metabolism Unit, School of Medicine, University of Southampton, Southampton, UK.

British Medical Bulletin
|January 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.

Diabetes & metabolism·2020
Same author

Patients with diabetes are at higher risk for severe illness from COVID-19.

Diabetes & metabolism·2020
Same author

Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease.

Diabetes & metabolism·2020
Same author

PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD.

Diabetes & metabolism·2020
Same author

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.

Diabetes & metabolism·2020
Same author

Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.

Diabetes & metabolism·2019
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Low birth weight and adult obesity increase metabolic syndrome risk. Hormonal pathways, including glucocorticoids and the growth hormone (GH)-insulin-like growth factor (IGF-1) axis, influence insulin resistance and metabolic syndrome development.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Developmental Biology

Background:

  • Metabolic syndrome significantly elevates risks for type 2 diabetes and atherosclerotic vascular disease (AVD).
  • Insulin resistance is a central characteristic of metabolic syndrome.
  • Early life factors like low birth weight, combined with adult obesity, are increasingly linked to metabolic syndrome prevalence.

Purpose of the Study:

  • To review hormonal programming influencing insulin action.
  • To explore the roles of glucocorticoid and GH-IGF-1 axes in metabolic syndrome pathogenesis.
  • To elucidate mechanisms connecting hormonal pathways to early growth, obesity, and metabolic syndrome.

Main Methods:

  • Literature review focusing on endocrine pathways modulating insulin sensitivity.

Related Experiment Videos

  • Analysis of mechanisms linking hormonal dysregulation to metabolic syndrome components.
  • Discussion of developmental influences on hormonal programming.

    • Main Results:

    • Hormones can potentiate or reduce insulin's biological actions, thereby affecting insulin resistance.
    • Aberrant activity in the glucocorticoid and GH-IGF-1 axes is implicated in metabolic syndrome.
    • These pathways potentially link abnormal early growth and adult obesity to metabolic syndrome.

    Conclusions:

    • Hormonal programming, particularly via glucocorticoids and the GH-IGF-1 axis, plays a critical role in metabolic syndrome.
    • Understanding these pathways offers insights into preventing and managing type 2 diabetes and AVD.
    • Early life influences on hormonal systems may predispose individuals to metabolic syndrome later in life.